Fundz

Co Regen reported raising $13.5 Million in an initial SEC Form D filing, from an offering of $13.5 Million

PRIVATEFeb 26, 2026Late filing, first sale Oct 28, 2025

Amount Raised

$13.5 Million

$13.5 Million sold, per SEC Form D (first sale Oct 28, 2025)

Round Type

Venture

HoustonBiotechnologyHealth CareTherapeutics

Quick answer

CoRegen raised $13.5 Million in a funding round, dated October 28, 2025. CoRegen is based in Houston, Texas, United States.

How much did CoRegen raise?
CoRegen raised $13.5 Million in a funding round on October 28, 2025.
What does CoRegen do?
CoRegen is leveraging its groundbreaking master gene regulator platform to develop a broad range of therapeutics capable of controlling numerous genes throughout the body, with lead indications in solid tumors.
Where is CoRegen based and how big is it?
CoRegen is based in Houston, Texas, United States.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as CoRegen that raised within 45 days of this round, from Fundz verified event records.

  • Cayuga Biotech raised $8M (Seed) on December 11, 2025.
  • Denali Therapeutics raised $200M (Post-IPO Equity) on December 10, 2025.
  • EpilepsyGTx raised $33M (Series A) on December 10, 2025.
  • Dyne Therapeutics raised $350M (Post-IPO Equity) on December 10, 2025.
  • D3 Bio raised $108M (Series B) on December 10, 2025.
  • Aprea Therapeutics raised $3.1M on December 10, 2025.

Who to call at CoRegen, and when

A new round usually means CoRegen is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CoRegen raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CoRegen, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CoRegen. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CoRegen

Location

Houston, Texas, United States

About

CoRegen is leveraging its groundbreaking master gene regulator platform to develop a broad range of therapeutics capable of controlling numerous genes throughout the body, with lead indications in solid tumors.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CoRegen raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for CoRegen's next move

See what Strategic adds

CoRegen raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.